Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy.

Saved in:
Bibliographic Details
Title: Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy.
Authors: Yoo J; Department of Radiology, Seoul National University Hospital, Seoul, Korea.; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea., Lee DH; Department of Radiology, Seoul National University Hospital, Seoul, Korea. dhlee.rad@gmail.com.; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea. dhlee.rad@gmail.com., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea., Yoon J; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Lee SH; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Cho IR; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Paik WH; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Source: European radiology [Eur Radiol] 2026 May 28. Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1084 (Electronic) Linking ISSN: 09387994 NLM ISO Abbreviation: Eur Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1084
DOI:10.1007/s00330-026-12645-x